Clinical Trials in Phoenix

Showing 1641-1660 of 16,646 trials

Active Not RecruitingEARLY Phase 1< 1 mile

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

NCT05182905

This is an open-label, single-center Phase 0/1b study that will enroll at least 27 participants with recurrent WHO Grade 4 Glioma requiring re-radiation and approximately 35 participants with newly-diagnosed WHO Grade 4 glioma (nGBM). The trial will be composed of a Phase 0 component (subdivided into Arms A - C), and an expansion Phase 1b. Patients with tumors demonstrating a positive PK response in the Phase 0 component of the study will be eligible to graduate to an expansion phase that combines therapeutic dosing of AZD1390 plus standard-of-care fractionated radiotherapy (RT).

GlioblastomaGliomaGlioblastoma Multiforme+1 more

Nader Sanai97 participantsStarted May 2022

Phoenix, Arizona, United States

RECRUITINGPhase 3< 1 mile

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

NCT07177352

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Alzheimers Disease

Hoffmann-La Roche13,000 participantsStarted Jul 2025

Phoenix, Arizona, United States • Sun City, Arizona, United States • Imperial, California, United States +204 more locations

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Find Trials by Condition in Phoenix

Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma

Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV

A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer